166 related articles for article (PubMed ID: 21168244)
1. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
[TBL] [Abstract][Full Text] [Related]
2. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
Calabrese E; Hanauer SB
J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
[TBL] [Abstract][Full Text] [Related]
3. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
Bryant DL; Miles CJ; Gearry RB
N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
[TBL] [Abstract][Full Text] [Related]
4. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
Ehmsen L; Marko C; Breidert M
Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
[TBL] [Abstract][Full Text] [Related]
5. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
[TBL] [Abstract][Full Text] [Related]
6. [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
Ruiz-Clavijo D; Arín A; Vila JJ; Albéniz E; Picazo R; Casi M
An Sist Sanit Navar; 2013 Sep; 36(2):353-6. PubMed ID: 24008542
[TBL] [Abstract][Full Text] [Related]
7. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.
Arnott ID; Ghosh S
Eur J Gastroenterol Hepatol; 2000 May; 12(5):569-73. PubMed ID: 10833103
[TBL] [Abstract][Full Text] [Related]
8. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
[TBL] [Abstract][Full Text] [Related]
9. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
Laish I; Pomeranz I; Kitay-Cohen Y; Konikof F
Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262
[TBL] [Abstract][Full Text] [Related]
10. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
Tuyama AC; Krakauer M; Alzaabi M; Fiel MI; Legnani P; Schiano TD
J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
[TBL] [Abstract][Full Text] [Related]
11. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
Dooremont D; Decaestecker J; De Wulf D; Ghillebert G; Van Vlierberghe H; Van Dorpe J; Baert F
Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
[TBL] [Abstract][Full Text] [Related]
13. Myelotoxicity and hepatotoxicity during azathioprine therapy.
de Boer NK; Mulder CJ; van Bodegraven AA
Neth J Med; 2005 Dec; 63(11):444-6. PubMed ID: 16397313
[TBL] [Abstract][Full Text] [Related]
14. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.
Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB
Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167
[TBL] [Abstract][Full Text] [Related]
15. Suspected azathioprine induced liver cirrhosis: an unusual side effect.
Trabelsi AB; Hamami E; Souguir A; Ksiaa M; Ajmi S; Jmaa A
Pan Afr Med J; 2014; 17():174. PubMed ID: 25392720
[TBL] [Abstract][Full Text] [Related]
16. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
[TBL] [Abstract][Full Text] [Related]
17. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
[TBL] [Abstract][Full Text] [Related]
18. Portal hypertension secondary to azathioprine in myasthenia gravis.
Fonseca V; Havard CW
Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
[TBL] [Abstract][Full Text] [Related]
19. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
Seiderer J; Zech CJ; Diebold J; Schoenberg SO; Brand S; Tillack C; Göke B; Ochsenkühn T
Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
[TBL] [Abstract][Full Text] [Related]
20. [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease].
Garrido Serrano A; Pérez Martín F; Guerrero Igea FJ; Galbarro Muñoz J; Palomo Gil S
Gastroenterol Hepatol; 2000 Jan; 23(1):7-8. PubMed ID: 10726375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
